Cargando…
A stochastic bi-objective simulation–optimization model for plasma supply chain in case of COVID-19 outbreak
As of March 24, 2020, the Food and Drug Administration (FDA) authorized to bleed the newly recovered from Coronavirus Disease 2019 (COVID-19), i.e., the ones whose lives were at risk, separate Plasma from their blood and inject it to COVID-19 patients. In many cases, as observed the plasma antibodie...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317469/ https://www.ncbi.nlm.nih.gov/pubmed/34335121 http://dx.doi.org/10.1016/j.asoc.2021.107725 |